stockportfolio.pro
Varex Imaging Corporation (VREX)
Healthcare · Medical Devices · NasdaqGS
Varex Imaging Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $620.10M | $698.10M | $773.40M | $780.60M | $738.30M | $818.10M | $859.40M | $893.40M | $811.00M | $844.60M |
| Gross profit | $248.40M | $253.50M | $253.90M | $256.70M | $190.20M | $271.50M | $283.50M | $290.30M | $256.90M | $290.50M |
| Net income | $68.50M | $51.60M | $27.50M | $15.50M | $-57.90M | $17.40M | $30.30M | $47.40M | $-48.80M | $-70.30M |
| Net margin | 11.0% | 7.4% | 3.6% | 2.0% | -7.8% | 2.1% | 3.5% | 5.3% | -6.0% | -8.3% |
Source: Varex Imaging Corporation SEC filings (10-K). 11 years of history available in the interactive view.
What growth is priced into VREX stock?
At today's market cap of $449.91M, Varex Imaging Corporation is priced for free-cash-flow growth of about 10.2% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $18.80M from the FY ending 2025-09-30). For comparison, revenue 2.7%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 11 years of Varex Imaging Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track VREX in your portfolio →
Varex Imaging Corporation financial history by metric
About Varex Imaging Corporation
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Varex Imaging Corporation — frequently asked questions
What is Varex Imaging Corporation's revenue?
Varex Imaging Corporation (VREX) reported revenue of $844.60M for fiscal year 2025, up 4.1% from the prior year, according to its SEC filings.
Is Varex Imaging Corporation profitable?
No — VREX reported a net loss of $-70.30M in fiscal 2025.
What is VREX's P/E ratio?
Varex Imaging Corporation trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Varex Imaging Corporation growing?
VREX's revenue grew at roughly 2.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Varex Imaging Corporation have?
As of fiscal year 2025, VREX carried roughly $367.50M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Varex Imaging Corporation's gross margin?
VREX's gross margin was 34.4% in fiscal 2025 — gross profit of $290.50M on revenue of $844.60M.
What is Varex Imaging Corporation's market cap?
Varex Imaging Corporation (VREX) has a market capitalization of about $449.91M, based on the latest data in our nightly-refreshed cache.
When does Varex Imaging Corporation's fiscal year end?
VREX's fiscal year ends in September. Its most recent annual filing covers the fiscal year ending 2025-09-30.
What growth is priced into VREX stock?
At today's market cap of $449.91M, Varex Imaging Corporation is priced for free-cash-flow growth of about 10.2% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $18.80M from the FY ending 2025-09-30). For comparison, revenue 2.7%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Varex Imaging Corporation's official SEC filings (10-K and 10-Q), covering 11 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.